Plozalizumab
N/A
Report date: 2022/07/19 16:22:54
Base Information
Drug NamePlozalizumab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteMillennium Pharmaceuticals IncTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications +[7]
Other Information
ATC CodeN/A
Related LinksWikipedia